Efficacy of Imiquimod in Treating Chlamydia Infection in Mice
Author Information
Author(s): Joseph M. Lyons, James I. Ito, Servaas A. Morré
Primary Institution: City of Hope National Medical Center and Beckman Research Institute
Hypothesis
Does vaginal application of imiquimod alter the course and outcome of Chlamydia trachomatis infection in a murine model?
Conclusion
Ongoing treatment with Aldara significantly reduces the duration of Chlamydia trachomatis infection in mice.
Supporting Evidence
- Imiquimod treatment reduced the median duration of infection from 19 days in placebo to 4 days in treated mice.
- 6 out of 8 treated mice were culture negative by day 4, while all placebo mice were positive.
- Imiquimod was administered on multiple occasions to assess its efficacy.
Takeaway
Using a special cream called Aldara before and during a Chlamydia infection helped mice get better faster.
Methodology
CF-1 mice were treated with Aldara on different schedules and infected with Chlamydia to monitor infection duration and shedding.
Limitations
The study was conducted in a murine model, which may not fully replicate human responses.
Participant Demographics
Female CF-1 mice, 7-8 weeks old.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website